These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19296526)

  • 1. Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.
    Albers AE; Schaefer C; Visus C; Gooding W; DeLeo AB; Whiteside TL
    Head Neck; 2009 Jun; 31(6):773-81. PubMed ID: 19296526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
    Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
    Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
    Hoffmann TK; Donnenberg AD; Finkelstein SD; Donnenberg VS; Friebe-Hoffmann U; Myers EN; Appella E; DeLeo AB; Whiteside TL
    Cancer Res; 2002 Jun; 62(12):3521-9. PubMed ID: 12067999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.
    Kuss I; Donnenberg AD; Gooding W; Whiteside TL
    Br J Cancer; 2003 Jan; 88(2):223-30. PubMed ID: 12610507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
    Tsukishiro T; Donnenberg AD; Whiteside TL
    Cancer Immunol Immunother; 2003 Oct; 52(10):599-607. PubMed ID: 12827303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites.
    Albers AE; Ferris RL; Kim GG; Chikamatsu K; DeLeo AB; Whiteside TL
    Cancer Immunol Immunother; 2005 Nov; 54(11):1072-81. PubMed ID: 15959774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.
    Czystowska M; Gooding W; Szczepanski MJ; Lopez-Abaitero A; Ferris RL; Johnson JT; Whiteside TL
    Clin Cancer Res; 2013 Feb; 19(4):889-99. PubMed ID: 23363813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis.
    Kim JW; Ferris RL; Whiteside TL
    Clin Cancer Res; 2005 Nov; 11(21):7901-10. PubMed ID: 16278415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
    Albers AE; Visus C; Tsukishiro T; Ferris RL; Gooding W; Whiteside TL; De Leo AB
    Clin Cancer Res; 2006 Apr; 12(8):2394-403. PubMed ID: 16638844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 as an immunotherapeutic target in head and neck cancer.
    Hoffmann TK; Bier H; Donnenberg AD; Whiteside TL; De Leo AB
    Adv Otorhinolaryngol; 2005; 62():151-60. PubMed ID: 15608425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer.
    Albers AE; Qian X; Kaufmann AM; Mytilineos D; Ferris RL; Hoffmann TK; DeLeo AB
    Sci Rep; 2018 Jul; 8(1):10716. PubMed ID: 30013227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.
    Saito T; Dworacki G; Gooding W; Lotze MT; Whiteside TL
    Clin Cancer Res; 2000 Apr; 6(4):1351-64. PubMed ID: 10778963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
    Walker EB; Haley D; Miller W; Floyd K; Wisner KP; Sanjuan N; Maecker H; Romero P; Hu HM; Alvord WG; Smith JW; Fox BA; Urba WJ
    Clin Cancer Res; 2004 Jan; 10(2):668-80. PubMed ID: 14760090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses.
    Schmitt A; Barth TF; Beyer E; Borchert F; Rojewski M; Chen J; Guillaume P; Gronau S; Greiner J; Möller P; Riechelmann H; Schmitt M
    Int J Oncol; 2009 Mar; 34(3):629-39. PubMed ID: 19212667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.
    Chimote AA; Hajdu P; Sfyris AM; Gleich BN; Wise-Draper T; Casper KA; Conforti L
    Cancer Res; 2017 Jan; 77(1):53-61. PubMed ID: 27815390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
    Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.